Trial site

Baylor Scott and White

Dallas, Texas 75246, United StatesNot linked to an institution yet

The trials here

What the 7 trials at this site are about, from their registry records.

Conditions: Coronary artery disease2 trials
Ulcerative colitis2 trials
Chronic kidney disease1 trial
Heart failure1 trial
IgA nephropathy1 trial
Meningioma1 trial
Phase: Phase 34 trials
Phase 22 trials
Status: Recruiting4 trials
Active, not recruiting2 trials
Completed1 trial
Lead sponsor: Abivax S.A.2 trials
Weill Medical College of Cornell University2 trials
Neonc Technologies, Inc.1 trial
Novartis Pharmaceuticals1 trial
Reprieve Cardiovascular, Inc1 trial

Recruiting
Fluid Management of Acute Decompensated Heart Failure Subjects Treated With Reprieve System (FASTR-II) (IDE-G210258)
NCT06898515· Reprieve Cardiovascular, Inc· Source
Contact: Annemarie Forrest
Recruiting
REvascularization CHoices Among Under-Represented Groups Evaluation: The RECHARGE Trial - Minorities
NCT06399705· Phase 3· Weill Medical College of Cornell University· Source
Contact: Mario Gaudino, MD, PhD, MSCE, FEBCTS, FACC
Recruiting
REvascularization CHoices Among Under-Represented Groups Evaluation: The RECHARGE Trial - Women
NCT06399692· Phase 3· Weill Medical College of Cornell University· Source
Contact: Mario Gaudino, MD, PhD, MSCE, FEBCTS, FACC
Active, not recruiting
ABTECT - Maintenance
NCT05535946· Phase 3· Abivax S.A.· Source
Recruiting
NEO100 and High-Grade Meningioma
NCT05023018· Phase 2· Neonc Technologies, Inc.· Source
Contact: Tarah Satterfield
Active, not recruiting
Atrasentan in Patients With Proteinuric Glomerular Diseases
NCT04573920· Phase 2· Novartis Pharmaceuticals· Source

How many trials recruit for the same indication here at once. A count, not a rating.

Site data: ClinicalTrials.govUpdated 12 Nov 2026